Vdrive Evaluation of Remote Steering and Testing in Lasso Electrophysiology Procedures Study

Phase 3

Completed

Interventions: Procedure: Manual Lasso navigation
Device: Vdrive Lasso navigation

Brief Summary: This study will evaluate the use of a robotic device that is remotely controlled to maneuver a circular mapping catheter in the left atrium during Atrial Fibrillation (AF) ablation procedures.

Detailed Description: Key to the success of an electrophysiology procedure is the ability to accurately map, sense and pace the heart. Electrophysiology mapping catheters are available in a variety of shapes and electrode configurations. The majority of these catheters are manipulated manually by the physician. The Vdrive simplifies these manipulations by allowing an operator to mechanically advance, retract, rotate, deflect and maneuver a circular mapping catheter. The circular mapping catheter is not altered in structure, function or indication in the same manner as the predicate device (Cardiodrive Catheter Advancement System).

This is a prospective, randomized, non-blinded, controlled study comparing manual navigation of a circular mapping catheter with mechanical navigation by the Vdrive. A total of 120 patients are expected to complete the study: 80 patients in the Vdrive navigation arm and 40 patients in the manual navigation arm. Patients will be enrolled at a minimum of one site in the European Union where the product is currently marketed and the United States, where the Vdrive is considered to be investigational.

Recruitment & Eligibility

Inclusion Criteria

Left atrial AF ablation procedure requiring the use of a Lasso mapping catheter
Subject must be at least 18 years of age
Subject must be male, female of no childbearing potential, or a female that has a negative pregnancy test prior to randomization

Exclusion Criteria

Unable to safely expose subject to a magnetic field
Prior AF ablation procedure
Patients with fewer than 4 PVs are excluded
Patients with persistent AF in whom early recurrence of AF following cardioversion would preclude completion of the pacing maneuvers described in the protocol or patients with other conditions that would similarly preclude completion of the pacing maneuvers
Contraindication to procedure or unable to return for follow-up
History of clotting disorder, bleeding abnormalities or contraindication to anticoagulation
Actively participating in other cardiac device trial(s)
Currently pregnant
Under 18 years of age
Prosthetic valves
Atrial abnormalities (thrombus, myxoma or baffle)
Other exclusions per the investigator

Arm && Interventions

Group	Intervention	Description
Manual Lasso navigation	Manual Lasso navigation	Use of conventional manual navigation techniques with the Lasso catheter
Vdrive Lasso navigation	Vdrive Lasso navigation	Use of the Vdrive to remotely and robotically control the manipulation of a Lasso catheter

Primary Outcome Measures

Name	Time	Method
Safety Outcome to be Assessed by Comparing the Rate of Adjudicated Serious Adverse Events Within 7 Days of the Procedure Between Both the Control and the Investigational Device Groups.	7 days Follow-up	The Vdrive will allow physicians to manipulate compatible circular mapping catheters while maintaining a safety profile that is not inferior to manual circular catheter navigation. The one-sided null hypothesis was to be tested at the α = 0.05 significance level using a standard unpooled asymptotically normal test statistic. The null hypothesis was to be rejected if Z \< -1.7046 or, equivalently, if the corresponding p-value was less than 0.05.
The Primary Effectiveness Endpoint is the Successful Navigation and EGM Recording of Each Pre-specified Pulmonary Vein Per Procedure Between Both the Control and the Investigational Device Groups.	Peri-procedural	Success was navigating and sensing by obtaining an EGM at the pre-specified targeted PVs. The null hypothesis was to be tested at the α = 0.05 significance level using a test statistic Z based on the Farrington and Manning likelihood score statistic with adjustment to take into account the correlation between multiple observations (PVs) on the same subject. The null hypothesis was to be rejected if Z \> 1.645 or, equivalently, if the corresponding p-value was less than 0.05.

Secondary Outcome Measures

Name	Time	Method

Locations (5): Texas Cardiac Arrhythmia Institute
🇺🇸
Austin, Texas, United States
ZNA Campus Middelheim Lindendreef 1
🇧🇪
Antwerpen, Belgium
Baylor Research Institute
🇺🇸
Dallas, Texas, United States
Central Baptist Hospital
🇺🇸
Lexington, Kentucky, United States
IKFE HDZ GbmH
🇩🇪
Bad Oeynhausen, Germany